Surgery Partners, Inc. SGRY
14.40
0.20
1.41%
as of 25 Sep
- Market cap
- $1.9B
- P/E
- 0.0×
Follow SGRY
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (2.83%) | (2.43%) | (2.46%) | (5.48%) |
+8 more TTM periods Free account |
|
| (1.11%) | (0.95%) | (0.97%) | (2.21%) | ||
ROIC |
3.61% | 3.71% | 3.69% | 3.91% | |
Return on Tangible Assets |
(5.30%) | (4.65%) | (4.61%) | (10.20%) | |
Average Days of Receivables |
66.86 | 65.87 | 66.43 | 64.31 | |
Free Cash Flow per Share |
1.49 | 1.95 | 1.90 | 1.87 | |
Free Cash Flow |
191.50 | 249.70 | 242.10 | 238.10 | |
Capital Expenditures |
(66.50) | (30.30) | (32.20) | (44.20) | |
Piotroski F-Score |
5.00 | 3.00 | 4.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
3.65% | 4.00% | 3.88% | 4.09% | |
Accounts Receivable Turnover |
5.71 | 5.70 | 5.60 | 5.86 | |
Accounts Payable Turnover |
14.90 | 15.47 | 12.19 | 14.49 | |
Inventory Turnover |
28.03 | 27.36 | 27.50 | 28.71 | |
Average Days of Payables |
24.52 | 23.85 | 29.95 | 25.47 | |
Days of Inventory on Hand |
13.83 | 14.22 | 13.86 | 13.47 | |
Tax Rate |
(0.20) | (0.15) | (1.19) | (0.87) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
3.62% | 3.63% | 3.57% | 3.97% | |
Share Based Compensation of Revenue |
0.30% | 0.39% | 0.45% | 0.71% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(2.91) | (3.68) | (3.52) | (1.65) | |
Depreciation/Fixed assets |
0.16 | 0.16 | 0.15 | 0.13 | |
Capex/Depreciation |
(0.38) | (0.17) | (0.18) | (0.29) | |
Revenue per Share |
26.13 | 26.05 | 26.01 | 25.85 | |
Operating CF per Share |
2.00 | 2.18 | 2.16 | 2.22 | |
Capex per Share |
(0.52) | (0.24) | (0.25) | (0.35) | |
Capex to Sales |
0.02 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(2.63%) | (2.28%) | (2.35%) | (5.21%) |
Columns are period end dates